Founded in 2013, Bioventure is based in Suzhou, China, and manages a fund of 540 million yuan. With a team of experienced investment professionals, Bioventure has a deep understanding of both domestic and foreign markets, enabling them to help portfolio startups grow rapidly and achieve success. The firm has a particular focus on the medical and pharmaceutical industry and has a strong track record of successful investments. They typically invest in rounds with 2-3 partners and have a preference for startups that are 6-10 years old. Some of their notable portfolio companies include inui Health, LAM Therapeutics, and Innovita Biological Technology.